Allergic Reaction
23
1
1
14
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
4.3%
1 terminated out of 23 trials
93.3%
+6.8% vs benchmark
9%
2 trials in Phase 3/4
21%
3 of 14 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 14 completed trials
Clinical Trials (23)
Nickel Sensitivity
Human Seminal Plasma Allergy: Quality of Life
Phleum Pratense and Dactylis Glomerata Allergen Extracts Standardization
Pharmacokinetics Study of DESF in Adults With Oral Allergy Syndrome
Standardised Drug Provocation Testing in Perioperative Hypersensitivity
COVID19 SARS Vaccinations: Systemic Allergic Reactions to SARS-CoV-2 Vaccinations
Quercus Ilex and Quercus Robur Allergen Extracts Standardisation
Prineo Sensitivity Dressing Study
Preoperative Survey to Evaluate Patient Allergy
Juniperus Oxycedrus and Cupressus Arizonica Allergen Extracts Standardisation.
Is There an Allergy to Pure Metallic Gold Microparticles?
Analysis of Adverse Events in Anesthesia Using Artificial Intelligence
Investigation of Cross-allergies Between Cefazolin and Amoxicillin With Skin Tests and Provocation Test
Development of Personalized Balanced Nutrition Concept Through an IT Platform
Assessment of Injectable Medication Platforms
Checklists Resuscitation Emergency Department
Epidemiology of Pecan Nut Allergy
Allergy Potential of Omeza Collagen Matrix in Human Subjects Using the Skin Prick Method
What is the Allergy Follow-up for Children After Anaphylactic Reaction? AFCAR : Allergy Follow-up for Children After Anaphylactic Reaction
Repeatability and Reproducibility of Skin Test Endpoint Titration